VAUGHAN, ON and HEIDELBERG, Germany, July 7, 2022 — Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better …
Topic:
Treatment
-
-
Inactivation of Suv39h1 Enhances Anti-Tumor Immune Response by Increasing T Cell Activity and Decreasing T Cell Exhaustion During Anti-PD-1 Treatment
by Your NewsPARIS, July 6, 2022 — Mnemo Therapeutics, a biotechnology company developing transformational immunotherapies, today announced a publication in Nature Communications demonstrating that the histone lysine methyltransferase enzyme Suv39h1 plays not …
-
Some long COVID patients still have virus in the blood; Paxlovid rebound patients may need longer treatment
by ReutersBy Nancy Lapid (Reuters) – The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has …
-
RADICAVA ORS gives people with ALS an oral treatment option that offers the same efficacy as the IV formulation of edaravone1 JERSEY CITY, N.J., June 15, 2022 — Mitsubishi Tanabe …
-
Schenectady, NY – With four fatal drug overdoses in the past week, the Schenectady Police Department today is advising residents of drug addiction resources throughout the area. “In just over …
-
Former Owner of Chicago Health Care Company Sentenced to a Year in Federal Prison for Billing Medicare for Non-Existent Treatment
by DOJ PressCHICAGO — The former owner of a Chicago home health care company has been sentenced to a year in federal prison for fraudulently obtaining $1.2 million from Medicare through a …
-
(Reuters) -The U.S. Food and Drug Administration said on Wednesday it has withdrawn its approval for TG Therapeutics Inc’s lymphatic cancer treatment Ukoniq over concerns of higher risk of death …
-
RECOVERY CENTERS OF AMERICA AT ST. CHARLES AND SOUTH ELGIN ANNOUNCE TWO NEW SPECIALIZED TREATMENT PROGRAMS, “DISCOVER” AND “BALANCE” DURING MAY MENTAL HEALTH AWARENESS MONTH
by Your News“Many young adults are suffering in silence now. They need SUD treatment but also suffer from mental health conditions.” Tweet this An analysis of government data has revealed that the …
-
Wyatt Detention Center to Provide Opioid Use Disorder Treatment to Detainees in Treatment Prior to Detention
by DOJ PressPROVIDENCE – United States Attorney Zachary A. Cunha announced today that his office has entered into an agreement with the Donald W. Wyatt Detention Facility (Wyatt) to ensure that detainees …
-
HARRISBURG (PRESS RELEASE) —Attorney General Josh Shapiro announced Southwest Nu-Stop Philadelphia Inc. (Southwest), a Philadelphia-based drug and alcohol treatment facility, and its owner Dr. Lloyd Reid pleaded guilty to Medicaid …
-
By Leroy Leo and Michael Erman (Reuters) – The U.S. Food and Drug Administration has decided not to authorize the antidepressant fluvoxamine to treat COVID-19, saying that the data has …
-
3 Found Guilty of Participating in Scheme to Submit Millions of Dollars in Fraudulent Bills for Substance Abuse Treatment for Teens
by DOJ PressLOS ANGELES – A federal jury today convicted three defendants who participated in an $18.5 million scheme that submitted fraudulent claims to California’s Drug Medi-Cal program for alcohol and …
-
Bausch + Lomb Presents Data from Second Pivotal Phase 3 Trial of Investigational Treatment NOV03 (Perfluorohexyloctane) at the Association for Research in Vision and Ophthalmology Annual Meeting
by Your NewsNOV03 Met Primary Endpoints for Signs and Symptoms of Dry Eye Disease Associated with Meibomian Gland Dysfunction in Both Phase 3 Trials VAUGHAN, ON and LAVAL, QC and HEIDELBERG, Germany, …
-
HACKENSACK, N.J., April 29, 2022 — With prices all around us rising to exorbitant amounts, it’s nice to know that one company wants to keep prices low – Diamond Braces. As …
-
Bausch + Lomb Presents Data from First Pivotal Phase 3 Trial of Investigational Treatment NOV03 (Perfluorohexyloctane) at the American Society of Cataract and Refractive Surgery Annual Meeting
by Your NewsNOV03 Met Both Primary Endpoints for Signs and Symptoms of Dry Eye Disease VAUGHAN, ON and LAVAL, QC and HEIDELBERG, Germany, April 25, 2022 — Bausch + Lomb, a leading …
-
HOUSTON -Marathon Petroleum Chief Executive Michael Hennigan said on Thursday he will continue leading the largest U.S. crude oil refiner while he undergoes treatment for throat cancer, according to a …
-
Colorado Substance Abuse Treatment Clinic and Owner Agree to Settle False Claims Act Allegations
by DOJ PressWASHINGTON – Springbok Health Inc., a medical clinic with locations in Colorado Springs and Pueblo West, Colorado, and Mark Jankelow, Springbok’s owner and Chief Executive Officer, have agreed to pay …
-
Treatment Developed by CHOP Researchers Prevents Hypoglycemia in Children with Hyperinsulinism
by Your News“There are currently very few medical treatments for HI, and those treatments are of limited effectiveness while also associated with significant side effects,” said senior study author Diva D. De …
-
Renewed Light celebrates the grand opening of its mental health treatment center in New Jersey. DEPTFORD, N.J., April 14, 2022 — Renewed Light celebrates the opening of its new mental …
-
Phase One of Recovery Works Martinsville—situated on 9.25 acres at 504 Grand Valley Boulevard—is a 32-bed withdrawal management (detox) and residential treatment center, and is the first program of several …
-
Alina Lodge Announces a 28-Day Minimum Stay for the Residential Addiction Treatment Program in Blairstown, New Jersey (with more extended duration programs available as needed). BLAIRSTOWN, N.J., April 6, 2022 — Alina …
-
FDA approves CartiHeal’s Implant for the Treatment of Cartilage and Osteochondral Defects
by Your NewsKFAR SABA, Israel, March 30, 2022 — CartiHeal Ltd, developer of implants for the treatment of cartilage and osteochondral defects in arthritic and non-arthritic knee-joints, today announced that the U.S. Food …
-
John Theurer Cancer Center Treats First Patient in U.S. with Investigational New Treatment for Brain Cancer
by Your NewsDSP-0390, an investigational new agent developed by Cambridge, Massachusetts-based Sumitomo Dainippon Pharma Oncology, is an inhibitor of emopamil-binding protein (EBP), a molecule in cholesterol biosynthesis. DSP-0390 has not been approved …
-
Bausch + Lomb and Clearside Biomedical Announce the U.S. Commercial Launch of XIPERE® (Triamcinolone Acetonide Injectable Suspension) For Suprachoroidal Use for the Treatment of Macular Edema Associated with Uveitis
by Your News“XIPERE® is the first and only therapy available in the United States that utilizes the suprachoroidal space to treat patients who struggle with macular edema associated with uveitis, which is …
-
HARRISBURG, PA — The former owner of M&S Sanitation Sewage Disposal and Pike County Environmental has been charged for repeatedly violating the Solid Waste Management Act. Attorney General Josh Shapiro …